Figlin RA - Search Results

1

Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With Sunitinib.

Sella A, Michaelson MD, Matczak E, Simantov R, Lin X, Figlin RA. Sella A, et al. Among authors: figlin ra. Clin Genitourin Cancer. 2017 Apr;15(2):291-299.e1. doi: 10.1016/j.clgc.2016.08.013. Epub 2016 Aug 18. Clin Genitourin Cancer. 2017. PMID: 27638198

2

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.

3

Immunotherapy for renal cell carcinoma.

Belldegrun A, Figlin R, Danella J, deKernion J. Belldegrun A, et al. Semin Urol. 1992 Feb;10(1):23-7. Semin Urol. 1992. PMID: 1565900 Review.

4

The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.

Figlin RA, Abi-Aad AS, Belldegrun A, deKernion JB. Figlin RA, et al. Semin Oncol. 1991 Oct;18(5 Suppl 7):102-7. Semin Oncol. 1991. PMID: 1719641 Review.

5

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.

Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB. Figlin RA, et al. Cancer. 1996 Sep 1;78(5):998-1003. doi: 10.1002/(SICI)1097-0142(19960901)78:5<998::AID-CNCR9>3.0.CO;2-8. Cancer. 1996. PMID: 8780537 Clinical Trial.

6

Current management of renal cell carcinoma.

Sokoloff MH, deKernion JB, Figlin RA, Belldegrun A. Sokoloff MH, et al. Among authors: figlin ra. CA Cancer J Clin. 1996 Sep-Oct;46(5):284-302. doi: 10.3322/canjclin.46.5.284. CA Cancer J Clin. 1996. PMID: 8806394 Free article. Review.

7

An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.

Nishikubo CY, Kunkel LA, Figlin R, Belldegrun A, Rosen P, Elashoff R, Wang H, Territo MC. Nishikubo CY, et al. Cancer. 1996 Dec 1;78(11):2421-6. Cancer. 1996. PMID: 8941014

8

Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.

Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, deKernion J, Belldegrun A. Figlin RA, et al. J Urol. 1997 Sep;158(3 Pt 1):740-5. doi: 10.1097/00005392-199709000-00012. J Urol. 1997. PMID: 9258071 Clinical Trial.

9

Renal cell carcinoma: recent progress and future directions.

Mulders P, Figlin R, deKernion JB, Wiltrout R, Linehan M, Parkinson D, deWolf W, Belldegrun A. Mulders P, et al. Cancer Res. 1997 Nov 15;57(22):5189-95. Cancer Res. 1997. PMID: 9371523 No abstract available.

10

Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.

Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, Belldegrun A. Figlin R, et al. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S92-7. Cancer J Sci Am. 1997. PMID: 9457402 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters